Upcoming amyloidosis clinical trial data to look forward to at ASH 2017
Trial of ibrutinib with bendamustine and rituximab in CLL: results and study design
Only the beginning of precision medicine and multiple myeloma.
How can the study of familial leukemias help us to understand sporadic leukemias?
Jane E. Churpek
Refining and improving treatment options in CLL